PV Bulletin

Regulator

EMA

Monitor European Medicines Agency pharmacovigilance and regulatory intelligence: PRAC signal assessments, EudraVigilance monitoring expectations under EU GVP, product information updates, and centrally authorised product safety actions. Each briefing maps EMA developments to workflows such as signal validation, label governance, and QPPV oversight.

4 updates · Sorted by impact priority

publicEuropean Medicines Agency (EMA) · European Union · Updated Jun 12, 2026

Product Management Service (PMS) public API beta release - Technical registration requirements

Urgency: High

MAHs and technical teams must review the revised API registration requirements and implement necessary system updates to comply by the established timelines.

Country ComplianceICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Technical Guidance
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Jun 5, 2026

EMA Updates Acceptable Intake Levels for Nitrosamine Impurities in Human Medicines

Urgency: High

Manufacturers must verify that their products meet the newly established acceptable intake levels for nitrosamines and implement necessary quality control measures to keep impurities within limits.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: Regulatory Update
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Jun 5, 2026

Ixchiq (Chikungunya vaccine (live)) - Safety measures following PRAC review

Urgency: High

Update product information and guidance for use in elderly populations for Ixchiq; ensure compliance with PRAC recommendations.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: PRAC recommendation
Read impact briefarrow_forward
publicEma · Updated May 22, 2026

MHRA reiterates GxP data integrity spans GVP as Annex 11 evolves

Urgency: High

Ema update requires triage for Local Affiliate Compliance, Vendor Oversight, Inspection Readiness; confirm local obligations and document follow-up actions.

Local Affiliate ComplianceVendor OversightQPPV
SOP Impact7 SOPs
ConfidenceMedium
Relevant for: QPPV, Local Safety Officer, Signal Management Lead
verifiedRegulatory action: AI/GxP
Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only